KAITLIN GALATA: Open Payments
NPI 1215217278 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,596 in 147 payments from 18 companies in 2025. Trend: 2023 $562 · 2024 $2,575 · 2025 $2,596
Food & beverage: $2,596
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $391 |
| ABBVIE INC. | 23 | $346 |
| UCB, Inc. | 21 | $325 |
| GENZYME CORPORATION | 14 | $282 |
| Novartis Pharmaceuticals Corporation | 14 | $190 |
| Incyte Corporation | 8 | $190 |
| Journey Medical Corporation | 3 | $145 |
| PFIZER INC. | 6 | $120 |
| Amgen Inc. | 4 | $98 |
| LEO Pharma Inc. | 4 | $89 |
Products named: TREMFYA, Bimzelx, DUPIXENT, RINVOQ, OPZELURA, SKYRIZI, COSENTYX, OTEZLA.
Industry payments across PA — which companies pay providers there.
